Venture capital · Est. 2016
1955 Capital
1955 Capital is a venture firm that backs companies spun out of frontier science, spanning energy, biology and health, food and resources, and computation. It engages with scientists and founders at the earliest stages.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is 1955 Capital right for your round?
Key stats
Fund cycle Public record
No fund vehicles on the public registers we read.
Latest investments
Rounds 1955 Capital joined, from press and the firm’s own posts.
Every round 1955 Capital joined
Round sizes, 1955 Capital’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company 1955 Capital backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet 1955 Capital
Events where 1955 Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
1955 Capital is based in the United States.
In 2016.
Sectors: Biotech, AI, Robotics. From the firm’s own website.
The firm targets the gap between scientific breakthroughs and commercial companies, investing before markets are obvious in areas where research outpaces venture funding. It builds deep thesis knowledge before investing and works with founders and scientists to shape technology, recruit talent and structure ventures. From the firm’s own website.
1955 Capital lists 9 portfolio companies on its website, including Nature’s Fynd, Noah Medical, Gridtential, Acuamark Dx and Craif.
Firms whose websites list some of the same companies include KUOS INVESTMENT II LLC, LYFE Capital and Phoenix Venture Partners.
Know before 1955 Capital’s next round is announced.
PRO tracks 1955 Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.